8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-25-031818
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading avtx-20250617.htm…